Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2020

View Archived Issues

New targets, new booster for CAR-T cells

As nanoparticles, vitamins fight sepsis

Targeting SMPD1 ameliorates leptin resistance-derived endothelial dysfunction in rats

ViiV Healtcare's Dovato receives approval in Japan for HIV infection

Cynata receives approval for its U.K. phase II study in critical limb ischemia

Kannalife presents additional data regarding the MOA of its leading candidate KLS-13019

NantKwest announces phase I data for PD-L1t.haNK

Alexion plans to initiate pivotal phase III CHAMPION-ALS study of Ultomiris in ALS

TROP2-targeted photoimmunotherapy shows promise in preclinical models

Zuclomiphene reduces moderate to severe hot flashes in men with prostate cancer on ADT

TCP-25 wound gel targets wound infection and inflammation in vivo

Cts Biopharma describes new anti-marinobufagenin antibodies

Cugene patents interleukin-2 variants

Kite Pharma discloses vectors encoding recombinant therapeutic T cells receptors

New gemcitabine prodrugs discovered at Shanghai Changchengyiyaokeji

Conatus Pharmaceuticals discovers caspase inhibitors

New STING receptor agonists discovered at Eternity Bioscience

Subtypes take on new importance as KRAS inhibitors proceed

NOTCH3 genetic variant found as a risk factor of stroke

Investigators report ZUMA-2 results with KTE-X19 in mantle cell lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...